Company: ELV
Filing Date: 2025-11-10
Form Type: 8-K
Source: 0001156039-25-000139
Chunk: 2

Company: Elevance Health, Inc.
Filing Date: 2025-11-10
Form: 8-K
Item: Item 7.01
Chunk 2
---
 do not adequately support goodwill and other intangible assets; possible restrictions in the payment of dividends from our subsidiaries and increases in required minimum levels of capital; our ability to repurchase shares of our common stock and pay dividends on our common stock due to the adequacy of our cash flow and earnings and other considerations; the potential negative effect from our substantial amount of outstanding indebtedness and the risk that increased interest rates or market volatility could impact our access to or further increase the cost of financing; a downgrade in our financial strength ratings; events that may negatively affect our licenses with the Blue Cross and Blue Shield Association; intense competition to attract and retain employees; risks associated with our international operations; and various laws and provisions in our governing documents that may prevent or discourage takeovers and business combinations.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized on this 10th day of November, 2025.

  ELEVANCE HEALTH, INC.                                                        
  By:                        /s/ Kathleen S. Kiefer                            
  Name:                      Kathleen S. Kiefer                                
  Title:                     Chief Governance Officer and Corporate Secretary